LBA49Neoadjuvant nivolumab (N) or nivolumab plus ipilimumab...

Annals of Oncology 2018 / 10 Vol. 29; Iss. suppl_8

LBA49Neoadjuvant nivolumab (N) or nivolumab plus ipilimumab (NI) for resectable non-small cell lung cancer (NSCLC)

Cascone, T, William, W N, Weissferdt, A, Leung, C H, Federico, L, Haymaker, C, Bernatchez, C, Fossella, F V, Mott, F E, Papadimitrakopoulou, V A, Byers, L, Lam, V K, Godoy, M C, Carter, B, Lee, J J, V
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
29
Language:
english
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdy424.059
Date:
October, 2018
File:
PDF, 95 KB
english, 2018
Conversion to is in progress
Conversion to is failed